Viktor Roschke
Förmögenhet: 30 M $ per 2026-05-31
Förmögenhet: 30 M $ per 2026-05-31
Viktor Roschke is the founder of Neuraly, Inc. since 2016, holding the title of Director & Chief Scientific Officer.
Current jobs include Secretary & Director at Theraly Fibrosis, Inc. and Chief Scientific Officer at D&D Pharmatech Co., Ltd. Former jobs include Executive Director-Cell Biology at Human Genome Sciences, Inc. from 2005, VP-Biopharmaceutical Research & Assay Development at Zyngenia, Inc., and Chief Operating Officer at Teva Biopharmaceuticals USA, Inc. Education includes a doctorate from Novosibirsk State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-04 | 482 036 ( 1,1 % ) | 30 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| D&D PHARMATECH INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Direktör/Styrelseledamot | - |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Grundare | 2016-01-01 |
| Företag | Position | Slut |
|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Företagsledare/Principal | 2005-01-01 |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Verksamhetschef | - |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Novosibirsk State University
Novosibirsk State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån